UNITED THERAPEUTICS Corp — Director's Dealing 2021

Jun 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-06-26

Reporting Person: Giltner Richard (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-26	Common Stock	M	3360	—	Acquired	11710	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-26	Restricted Stock Units	$0	M	3360	Disposed		Common Stock (3360)	Direct

Footnotes

F1: Shares received upon vesting of restricted stock united on June 26, 2021. Restricted stock units converted on a one-for-one basis into shares of common stock.

F2: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

F3: The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares.